Marisol Betensky MD

PubMed

• 1 citations
  Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT Trial.
  Hope P Wilson, Maua Mosha, Alexandra Miller, Marisol Betensky, Ernest Amankwah
  Seminars in Thrombosis and Hemostasis. 2025-04-01
• Recurrent Thromboembolism in Pediatric Congenital Heart Disease: Cumulative Incidence and Prognostic Factors.
  Amy L Kiskaddon, Therese M Giglia, Marisol Betensky, Nhue L Do, Daniel M Witt
  Seminars in Thrombosis and Hemostasis. 2025-04-01
• Anticoagulants in Children with Renal Impairment: A Narrative Review.
  Amy L Kiskaddon, Daniel M Witt, Marisol Betensky, Anthony A Sochet, Amanda Memken
  Seminars in Thrombosis and Hemostasis. 2025-03-28

Abstracts/Posters

• Identifying Primary Immune Deficiencies in Patients with Autoimmune Cytopenias
  Marisol Betensky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Risk Factors for Pediatric Cerebral Sinovenous Thrombosis: A Case-Control Study with Pediatric Neuroradiologist Case Validation
  Marisol Betensky, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• A Rise in Plasma Coagulability during the First 3 Months Following Provoked Venous Thromboembolism Is Associated with the Development of Post-Thrombotic Syndrome in Ch... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019